{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:54:49Z","timestamp":1790812489085,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160490"],"award-info":[{"award-number":["82160490"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02929-5","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:02:41Z","timestamp":1790809361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Carbon nanoparticle-Fe (II) complex for ferroptosis therapy in refractory solid tumors: a phase I trial"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9958-9892","authenticated-orcid":false,"given":"Huashan","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehui","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songpu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1289-5943","authenticated-orcid":false,"given":"Jianqiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"2929_CR1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-025-08974-4","volume":"642","author":"T Ca\u00f1eque","year":"2025","unstructured":"Ca\u00f1eque, T. et al. Activation of lysosomal iron triggers ferroptosis in cancer. Nature 642, 492\u2013500 (2025).","journal-title":"Nature"},{"key":"2929_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer, M. J. et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature 551, 247\u2013250 (2017).","journal-title":"Nature"},{"key":"2929_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang, X., Stockwell, B. R. & Conrad, M. Ferroptosis: mechanisms, biology and role in disease. Nat. Rev. Mol. Cell Biol. 22, 266\u2013282 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2929_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei, G., Zhuang, L. & Gan, B. The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell 42, 513\u2013534 (2024).","journal-title":"Cancer Cell"},{"key":"2929_CR5","first-page":"273","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell, B. R. et al. Ferroptosis: a regulated cell death nexus linking metabolism. Redox Biol., Dis. Cell. 171, 273\u2013285 (2017).","journal-title":"Redox Biol., Dis. Cell."},{"key":"2929_CR6","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1158\/0008-5472.CAN-25-3728","volume":"86","author":"C Mao","year":"2026","unstructured":"Mao, C. et al. DHODH-mediated suppression of ferroptosis supports radioresistance and represents a therapeutic vulnerability in Lung Cancer. Cancer Res. 86, 3309\u20133324 (2026).","journal-title":"Cancer Res."},{"key":"2929_CR7","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072 (2012).","journal-title":"Cell"},{"key":"2929_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","volume":"30","author":"G Lei","year":"2020","unstructured":"Lei, G. et al. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res. 30, 146\u2013162 (2020).","journal-title":"Cell Res."},{"key":"2929_CR9","doi-asserted-by":"publisher","first-page":"103796","DOI":"10.1016\/j.redox.2025.103796","volume":"86","author":"J Zhu","year":"2025","unstructured":"Zhu, J. et al. Ferroptosis triggers anti-tumor immunity via promoting chaperone-mediated autophagic degradation of SHP2. Redox Biol. 86, 103796 (2025).","journal-title":"Redox Biol."},{"key":"2929_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3049","volume":"15","author":"J Li","year":"2023","unstructured":"Li, J. et al. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Sci. Transl. Med. 15, eadg3049 (2023).","journal-title":"Sci. Transl. Med."},{"key":"2929_CR11","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.cell.2025.12.002","volume":"189","author":"J Liu","year":"2026","unstructured":"Liu, J. et al. Extracellular GPX4 impairs antitumor immunity via dendritic ZP3 receptors. Cell 189, 1056\u20131073 (2026).","journal-title":"Cell"},{"key":"2929_CR12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","volume":"612","author":"R Kim","year":"2022","unstructured":"Kim, R. et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature 612, 338\u2013346 (2022).","journal-title":"Nature"},{"key":"2929_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang, W. S. et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317\u2013331 (2014).","journal-title":"Cell"},{"key":"2929_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll, S. et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575, 693\u2013698 (2019).","journal-title":"Nature"},{"key":"2929_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou, Q. et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct. Target. Ther. 9, 55 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2929_CR16","doi-asserted-by":"publisher","first-page":"102719","DOI":"10.1016\/j.redox.2023.102719","volume":"63","author":"DM Cheff","year":"2023","unstructured":"Cheff, D. M. et al. Development of an assay pipeline for the discovery of novel small molecule inhibitors of human glutathione peroxidases GPX1 and GPX4. Redox Biol. 63, 102719 (2023).","journal-title":"Redox Biol."},{"key":"2929_CR17","doi-asserted-by":"publisher","first-page":"102703","DOI":"10.1016\/j.redox.2023.102703","volume":"62","author":"DM Cheff","year":"2023","unstructured":"Cheff, D. M. et al. The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1. Redox Biol. 62, 102703 (2023).","journal-title":"Redox Biol."},{"key":"2929_CR18","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun, L. et al. Smart nanoparticles for cancer therapy. Signal Transduct. Target. Ther. 8, 418 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2929_CR19","first-page":"188","volume":"16","author":"A Sheikh","year":"2024","unstructured":"Sheikh, A. et al. Understanding the novel approach of nanoferroptosis for cancer therapy. Nanomicro Lett. 16, 188 (2024).","journal-title":"Nanomicro Lett."},{"key":"2929_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61675-4","volume":"16","author":"M Dong","year":"2025","unstructured":"Dong, M. et al. Living therapeutics of nonpathogenic bacteria as biosynthesis factory and active carriers for enhancing tumor-targeted therapy. Nat. Commun. 16, 6532 (2025).","journal-title":"Nat. Commun."},{"key":"2929_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202412227","volume":"36","author":"Z Hu","year":"2024","unstructured":"Hu, Z. et al. NIR-actuated ferroptosis nanomotor for enhanced tumor penetration and therapy. Adv. Mater. 36, e2412227 (2024).","journal-title":"Adv. Mater."},{"key":"2929_CR22","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1021\/nn401196a","volume":"7","author":"C Cha","year":"2013","unstructured":"Cha, C., Shin, S. R., Annabi, N., Dokmeci, M. R. & Khademhosseini, A. Carbon-based nanomaterials: multifunctional materials for biomedical engineering. ACS Nano 7, 2891\u20132897 (2013).","journal-title":"ACS Nano"},{"key":"2929_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202400142","volume":"36","author":"X Pan","year":"2024","unstructured":"Pan, X. et al. MOF-derived nanoparticles with enhanced acoustical performance for efficient mechano-sonodynamic therapy. Adv. Mater. 36, e2400142 (2024).","journal-title":"Adv. Mater."},{"key":"2929_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202408685","volume":"36","author":"Q Cheng","year":"2024","unstructured":"Cheng, Q. et al. Photocatalytic carbon dots-triggered pyroptosis for whole cancer cell vaccines. Adv. Mater. 36, e2408685 (2024).","journal-title":"Adv. Mater."},{"key":"2929_CR25","doi-asserted-by":"publisher","first-page":"115604","DOI":"10.1016\/j.addr.2025.115604","volume":"222","author":"M Eftekharifar","year":"2025","unstructured":"Eftekharifar, M., Heidari, R., Mohaghegh, N., Najafabadi, A. H. & Heidari, H. Advances in photoactivated carbon-based nanostructured materials for targeted cancer therapy. Adv. Drug Deliv. Rev. 222, 115604 (2025).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2929_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201800525","volume":"7","author":"J Saleem","year":"2018","unstructured":"Saleem, J., Wang, L. & Chen, C. Carbon-based nanomaterials for cancer therapy via targeting tumor microenvironment. Adv. Healthc. Mater. 7, e1800525 (2018).","journal-title":"Adv. Healthc. Mater."},{"key":"2929_CR27","doi-asserted-by":"publisher","first-page":"46079","DOI":"10.1021\/acsami.4c09215","volume":"16","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. NIR-II responsive Fe-doped carbon nanoparticles for photothermal-enhanced chemodynamic synergistic oncotherapy. ACS Appl. Mater. Interfaces 16, 46079\u201346089 (2024).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2929_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2174\/0109298673287448240311112523","volume":"32","author":"Y Xing","year":"2025","unstructured":"Xing, Y. et al. Carbon-based nanomaterials in photothermal therapy guided by photoacoustic imaging: state of knowledge and recent advances. Curr. Med. Chem. 32, 238\u2013257 (2025).","journal-title":"Curr. Med. Chem."},{"key":"2929_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202401009","volume":"13","author":"J Xie","year":"2024","unstructured":"Xie, J. et al. Nano-titanium oxide-coated carbon nanotubes for photothermal therapy in the treatment of colorectal cancer. Adv. Healthc. Mater. 13, e2401009 (2024).","journal-title":"Adv. Healthc. Mater."},{"key":"2929_CR30","doi-asserted-by":"publisher","first-page":"13592","DOI":"10.1021\/acsami.4c21734","volume":"17","author":"H Li","year":"2025","unstructured":"Li, H. et al. A multifunctional nanoplatform based on carbon nanotubes loaded with persistent luminescent nanoparticles for photocatalysis, photothermal therapy, and drug delivery applications. ACS Appl. Mater. Interfaces 17, 13592\u201313604 (2025).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2929_CR31","doi-asserted-by":"publisher","first-page":"113968","DOI":"10.1016\/j.colsurfb.2024.113968","volume":"240","author":"Z Gou","year":"2024","unstructured":"Gou, Z. et al. Photothermal therapy of xenografted tumor by carbon nanoparticles-Fe(II) complex. Colloids Surf., B. 240, 113968 (2024).","journal-title":"Colloids Surf., B."},{"key":"2929_CR32","first-page":"29094","volume":"12","author":"P Xie","year":"2020","unstructured":"Xie, P. et al. Carbon nanoparticles-Fe(II) complex for efficient tumor inhibition with low toxicity by amplifying oxidative stress. ACS Appl. Mater. Interfaces 12, 29094\u201329102 (2020).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2929_CR33","doi-asserted-by":"publisher","first-page":"114562","DOI":"10.1016\/j.colsurfb.2025.114562","volume":"250","author":"P Xie","year":"2025","unstructured":"Xie, P. et al. Carbon nanoparticles-Fe(II) complex combined with sorafenib for ferroptosis-induced antitumor effects in triple-negative breast cancer. Colloids Surf., B. 250, 114562 (2025).","journal-title":"Colloids Surf., B."},{"key":"2929_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade9585","volume":"9","author":"A Anandhan","year":"2023","unstructured":"Anandhan, A. et al. NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8. Sci. Adv. 9, eade9585 (2023).","journal-title":"Sci. Adv."},{"key":"2929_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2143-7","volume":"10","author":"M Gagliardi","year":"2019","unstructured":"Gagliardi, M. et al. Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. Cell Death Dis. 10, 902 (2019).","journal-title":"Cell Death Dis."},{"key":"2929_CR36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan, V. S. et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature 547, 453\u2013457 (2017).","journal-title":"Nature"},{"key":"2929_CR37","doi-asserted-by":"publisher","first-page":"115933","DOI":"10.1016\/j.bcp.2023.115933","volume":"219","author":"X Zhang","year":"2024","unstructured":"Zhang, X., Li, X., Xia, R. & Zhang, H. Ferroptosis resistance in cancer: recent advances and future perspectives. Biochem. Pharmacol. 219, 115933 (2024).","journal-title":"Biochem. Pharmacol."},{"key":"2929_CR38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cytogfr.2023.08.004","volume":"75","author":"X Zhai","year":"2024","unstructured":"Zhai, X. et al. Ferroptosis in cancer immunity and immunotherapy: multifaceted interplay and clinical implications. Cytokine Growth Factor Rev. 75, 101\u2013109 (2024).","journal-title":"Cytokine Growth Factor Rev."},{"key":"2929_CR39","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.immuni.2024.03.019","volume":"57","author":"HN Bell","year":"2024","unstructured":"Bell, H. N., Stockwell, B. R. & Zou, W. Ironing out the role of ferroptosis in immunity. Immunity 57, 941\u2013956 (2024).","journal-title":"Immunity"},{"key":"2929_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","volume":"35","author":"F Yang","year":"2023","unstructured":"Yang, F. et al. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell Metab. 35, 84\u2013100 (2023).","journal-title":"Cell Metab."},{"key":"2929_CR41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2315541121","volume":"121","author":"H Li","year":"2024","unstructured":"Li, H. et al. USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy. Proc. Natl. Acad. Sci. USA. 121, e2315541121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2929_CR42","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao, P. et al. CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell 40, 365\u2013378 (2022).","journal-title":"Cancer Cell"},{"key":"2929_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41392-024-01772-w","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma, L. et al. Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer. Signal Transduct. Target. Ther. 9, 64 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2929_CR44","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569, 270\u2013274 (2019).","journal-title":"Nature"},{"key":"2929_CR45","doi-asserted-by":"publisher","first-page":"121315","DOI":"10.1016\/j.biomaterials.2021.121315","volume":"280","author":"W Han","year":"2022","unstructured":"Han, W. et al. Co-delivery of dihydroartemisinin and pyropheophorbide-iron elicits ferroptosis to potentiate cancer immunotherapy. Biomaterials 280, 121315 (2022).","journal-title":"Biomaterials"},{"key":"2929_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004381","volume":"10","author":"W Guo","year":"2022","unstructured":"Guo, W. et al. Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis. J. Immunother. Cancer 10, e004381 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"2929_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202303438","volume":"19","author":"H Lei","year":"2023","unstructured":"Lei, H. et al. Nonferrous ferroptosis inducer manganese molybdate nanoparticles to enhance tumor immunotherapy. Small 19, e2303438 (2023).","journal-title":"Small"},{"key":"2929_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202310309","volume":"11","author":"Y Li","year":"2024","unstructured":"Li, Y., Liu, J., Chen, Y., Weichselbaum, R. R. & Lin, W. Nanoparticles synergize ferroptosis and cuproptosis to potentiate cancer immunotherapy. Adv. Sci. 11, e2310309 (2024).","journal-title":"Adv. Sci."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02929-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02929-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02929-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:02:42Z","timestamp":1790809362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02929-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2929"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02929-5","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.X. is the CMO of Sichuan Enray Pharmaceutical Sciences Company. Y.H., and Y.C. are employees of Sichuan Enray Pharmaceutical Sciences Company. Y.W. is the editorial board member of the journal and he was not involved in the peer review or the decision making of this article. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"421"}}